EUVIMEDEUVIMED entdecken
Open Access

Utility of [ 18 F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging

Ana M Franceschi iD, Shichun Peng, Jorge Irias Banegas, Graham Keir iD, Marc L Gordon iD, David Eidelberg, Yilong Ma

American Journal of Neuroradiology · 2026

DOI: 10.3174/ajnr.a8980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2026. Verfasst von Ana M Franceschi und 6 weiteren Autor:innen. Beteiligte Einrichtung: From the Neuroradiology Division (A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hos…. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, tau Proteins, Brain. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePositron-Emission Tomographytau ProteinsBrainHumansFemaleMaleBiomarkersAged, 80 and overRadiopharmaceuticalsAgedMiddle AgedSensitivity and SpecificityReproducibility of ResultsFluorine RadioisotopesPyridines

Substanzen

BiomarkersRadiopharmaceuticalstau Proteins((18)F)PI-2620PI-2620Fluorine RadioisotopesPyridines

Autor:innen und Institutionen

  • From the Neuroradiology Division (A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, New York afranceschi@northwell.edu.
  • Center for Neurosciences, Institute of Molecular Medicine (S.P., J.I.B., D.E., Y.M.), Feinstein Institutes for Medical Research, Manhasset, New York.
  • Piedmont South Imaging (G.K.), Atlanta, Georgia.
  • The Litwin-Zucker Research Center (M.L.G.), Feinstein Institutes for Medical Research. Manhasset, New York.
  • Departments of Neurology and Psychiatry (M.L.G.), Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
  • Department of Molecular Medicine (D.E., Y.M.), Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

ORCID-Profile: Ana M Franceschi, Graham Keir, Marc L Gordon

Zitieren

APA

Franceschi, A. M., Peng, S., Banegas, J. I., Keir, G., Gordon, M. L., Eidelberg, D., & Ma, Y. (2026). Utility of [ 18 F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8980

Vancouver

Franceschi AM, Peng S, Banegas JI, Keir G, Gordon ML, Eidelberg D, et al. Utility of [ 18 F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging. American Journal of Neuroradiology. 2026. doi:10.3174/ajnr.a8980

BibTeX
@article{Franceschi2026,
  author = {Franceschi, Ana M and Peng, Shichun and Banegas, Jorge Irias and Keir, Graham and Gordon, Marc L and Eidelberg, David and Ma, Yilong},
  title = {Utility of [ 18 F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging},
  journal = {American Journal of Neuroradiology},
  year = {2026},
  doi = {10.3174/ajnr.a8980}
}
Kostenlos starten →